| pubmed-article:14521706 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14521706 | lifeskim:mentions | umls-concept:C0021051 | lld:lifeskim |
| pubmed-article:14521706 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:14521706 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:14521706 | lifeskim:mentions | umls-concept:C0040252 | lld:lifeskim |
| pubmed-article:14521706 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:14521706 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
| pubmed-article:14521706 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:14521706 | lifeskim:mentions | umls-concept:C0085973 | lld:lifeskim |
| pubmed-article:14521706 | lifeskim:mentions | umls-concept:C0007320 | lld:lifeskim |
| pubmed-article:14521706 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:14521706 | pubmed:dateCreated | 2003-10-2 | lld:pubmed |
| pubmed-article:14521706 | pubmed:abstractText | Dermatophytosis in immunocompromised hosts is more varied and often more severe than in immunocompetent hosts. Early recognition and treatment with systemic therapy are important in human immunodeficiency virus (HIV)-positive patients in order to prevent severe infection. Potential drug resistance can occur due to chronic usage of systemic azole therapy in such patients, or the existence of atypical fungi. Although warnings have been made of possible drug interactions between certain antifungals and antiretroviral medications, only one combination has shown a clinically significant interaction. A case treated aggressively with oral terbinafine at the onset is presented. | lld:pubmed |
| pubmed-article:14521706 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14521706 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14521706 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14521706 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14521706 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14521706 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14521706 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14521706 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:14521706 | pubmed:issn | 0011-9059 | lld:pubmed |
| pubmed-article:14521706 | pubmed:author | pubmed-author:BurkhartCraig... | lld:pubmed |
| pubmed-article:14521706 | pubmed:author | pubmed-author:GottwaldLorie... | lld:pubmed |
| pubmed-article:14521706 | pubmed:author | pubmed-author:ChangHowardH | lld:pubmed |
| pubmed-article:14521706 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14521706 | pubmed:volume | 42 | lld:pubmed |
| pubmed-article:14521706 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14521706 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14521706 | pubmed:pagination | 839-43 | lld:pubmed |
| pubmed-article:14521706 | pubmed:dateRevised | 2006-10-30 | lld:pubmed |
| pubmed-article:14521706 | pubmed:meshHeading | pubmed-meshheading:14521706... | lld:pubmed |
| pubmed-article:14521706 | pubmed:meshHeading | pubmed-meshheading:14521706... | lld:pubmed |
| pubmed-article:14521706 | pubmed:meshHeading | pubmed-meshheading:14521706... | lld:pubmed |
| pubmed-article:14521706 | pubmed:meshHeading | pubmed-meshheading:14521706... | lld:pubmed |
| pubmed-article:14521706 | pubmed:meshHeading | pubmed-meshheading:14521706... | lld:pubmed |
| pubmed-article:14521706 | pubmed:meshHeading | pubmed-meshheading:14521706... | lld:pubmed |
| pubmed-article:14521706 | pubmed:meshHeading | pubmed-meshheading:14521706... | lld:pubmed |
| pubmed-article:14521706 | pubmed:meshHeading | pubmed-meshheading:14521706... | lld:pubmed |
| pubmed-article:14521706 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:14521706 | pubmed:articleTitle | Tinea corporis in human immunodeficiency virus-positive patients: case report and assessment of oral therapy. | lld:pubmed |
| pubmed-article:14521706 | pubmed:affiliation | Department of Microbiology and Immunology, Medical College of Ohio, Toledo, Ohio 43623, USA. cburkhart@mco.edu | lld:pubmed |
| pubmed-article:14521706 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14521706 | pubmed:publicationType | Review | lld:pubmed |
